| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.08 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.08 |